Highlights Kintara Therapeutics, Inc.

Equities

KTRA

US49720K2006

Delayed Nasdaq Other stock markets 21:00:00 18/06/2024 BST			5-day change	1st Jan Change
0.216 ^USD	+20.67%		+13.09%	+27.36%

06-03	TuHura Biosciences, Inc. and Kintara Therapeutics, Inc. Announces Positive Results from Phase 1b Trial of IFx-2.0	CI
05-14	Kintara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

TuHura Biosciences, Inc. and Kintara Therapeutics, Inc. Announces Positive Results from Phase 1b Trial of IFx-2.0	06-03	CI
Kintara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-14	CI
Sector Update: Health Care Stocks Softer Late Afternoon	04-03	MT
Sector Update: Health Care	04-03	MT
Top Midday Gainers	04-03	MT
TuHURA Biosciences, Inc. entered into a definitive agreement to acquire Kintara Therapeutics, Inc. in a reverse merger transaction.	04-02	CI
TuHURA Biosciences, Inc. agreed to acquire Kintara Therapeutics, Inc. in a reverse merger transaction.	04-02	CI
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab	03-27	CI
Kintara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-14	CI
Kintara Therapeutics, Inc. Announces Initiation of Rem-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer	02-12	CI
Kintara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	11-13	CI
Kintara Therapeutics Announces Preliminary Topline Results from GBM AGile Study	31/10/23	CI
Kintara Therapeutics, Inc. Presents Case Studies of Glioblastoma Patients Treated with VAL-083 at 2023 European Association for Neuro-Oncology Annual Meeting	25/09/23	CI
Kintara Therapeutics, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	18/09/23	CI
Bank Stocks Lift Exchange-Traded Funds, Equity Futures Pre-Bell Thursday After Stress Test Results	29/06/23	MT
Kintara Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	11/05/23	CI
Kintara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	14/02/23	CI
Kintara Therapeutics Receives Orphan Drug Designation for VAL-083 for Treatment of Diffuse Intrinsic Pontine Glioma	15/12/22	CI
Kintara Therapeutics Regains Compliance With Nasdaq's Minimum Bid Price Requirement	30/11/22	MT
Kintara Therapeutics Grants Fast Track Designation from FDA for Rem-001 for Cutaneous Metastatic Breast Cancer	28/11/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kintara Therapeutics, Inc.

Equities

KTRA

US49720K2006

Highlights

Filters